Trump Owned by Big Pharma, Meaning FDA AND Gilead AND Others

The ‘very, very bad look' of remdesivir, the first FDA-approved COVID-19 drug | Science | AAAS https://t.co/iPMvUPThNa

— St. Michael, the Archangel (@aveng_angel) July 25, 2023

I really don't like this photo of Trump being squeezed on the left and right side of his desk.  He looks trapped or captured.  

The caption reads President Donald Trump and Food and Drug Administration Commissioner Stephen Hahn (right) met with Daniel O'Day (left) CEO of Gilead Sciences when Rendezvous received an emergency use authorization in May.  

Well, isn't this something?  When everybody was screaming "Early treatment, early treatment," it turns out that Gilead was the approved early treatment sanctioned by the FDA for use against the coronavirus.  In fact, it was the first drug to receive that status.  Two weeks after already sealing a deal worth $1 billion, Gilead, the owners of Remdesivir, got approval against COVID.

Two weeks later, on 22 October, the U.S. Food and Drug Administration (FDA) approved remdesivir for use against the pandemic coronavirus SARS-CoV-2 in the United States—the first drug to receive that status. The EU and U.S. decisions pave the way for Gilead's drug into two major markets, both with soaring COVID-19 cases. 

How in the world could the FDA approve Remdesivir after the failed trials?  Dr. Bryan Ardis says that Remdesivir was a bust.  It increases death by 3%, and increases renal failure by 20%.